The company has received approval from the United States Food and Drug Administration (FDA) to market the generic version of Bausch Health Americas' Jublia topical solution, the Mumbai-based drug maker said in a regulatory filing. Drug major Lupin on Thursday said it has received approval from the US health regulator to market Efinaconazole topical solution, used to treat fungal toenail infections, in the American market. The company has received approval from the United States Food and Drug Administration (FDA) to market the generic version of Bausch Health Americas' Jublia topical solution, the Mumbai-based drug maker said in a regulatory filing. The product will be manufactured at the company's facility in Pithampur, it added. estimated annual sales of USD 274 million in the US.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!